Press Releases 2024

Biocon Biologics  /  Press Releases  /  Press Releases 2024

Biocon Q2FY25 Revenue at Rs 3,623 Cr, EBITDA at Rs 718 Cr

  • Posted by: Biocon Biologics

Biocon Continues to be Among Science Magazine’s Top 10 Global Employers List

  • Posted by: Biocon Biologics

Biocon Foundation Honored with ‘Doing Good for Bharat Awards 2024’ in ‘Healthcare Category’ for ‘eLAJ Smart Clinics’ by the CSR Box

  • Posted by: Biocon Biologics

Biocon Biologics Announces Results of Aflibercept Switching Study at American Academy of Ophthalmology Annual Meeting

  • Posted by: Biocon Biologics

Biocon Biologics’ Commissioned Report Highlights Pathways to Increase Adoption of Biosimilars in LMICs

  • Posted by: Biocon Biologics

Biocon Biologics Refinances USD 1.1 Billion (INR 93,468 million) Long Term Debt through USD Bonds and New Syndicated Facility

  • Posted by: Biocon Biologics

Biocon Biologics Announces New Dermatology Data to Be Presented at EADV Congress 2024

  • Posted by: Biocon Biologics

Biocon Biologics Secures Market Entry for Bmab 1200, a Proposed Biosimilar to Stelara®, in Europe, UK, Canada, and Japan

  • Posted by: Biocon Biologics

Biocon Q1FY25 Revenue up 30% at Rs 4,567 Cr EBITDA up 117% at Rs 1,755 Cr Net Profit at Rs 660 Cr

  • Posted by: Biocon Biologics

Biocon Foundation and IISc organize OCTF Conference on Artificial Intelligence in Oral Cancer

  • Posted by: Biocon Biologics
Share
buy twitter followers